AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 69 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $22 | -45.0% | 12,192 | -44.6% | 0.00% | – |
Q4 2022 | $40 | -100.0% | 22,025 | -36.9% | 0.00% | -100.0% |
Q2 2022 | $98,000 | -52.0% | 34,888 | +11.5% | 0.00% | 0.0% |
Q3 2021 | $204,000 | +750.0% | 31,289 | +1417.4% | 0.00% | – |
Q3 2020 | $24,000 | -65.2% | 2,062 | -52.0% | 0.00% | – |
Q2 2020 | $69,000 | – | 4,295 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 7,346,829 | $15,723,000 | 27.32% |
TFG Asset Management GP Ltd | 3,039,381 | $6,504,000 | 0.78% |
Nantahala Capital Management | 5,215,788 | $11,162,000 | 0.72% |
Frazier Life Sciences Management, L.P. | 3,746,857 | $8,018,000 | 0.62% |
HARBOR CAPITAL ADVISORS, INC. | 148,454 | $318,000 | 0.29% |
DAFNA Capital Management LLC | 496,150 | $1,062,000 | 0.29% |
Blackstone Inc. | 17,985,611 | $38,489 | 0.14% |
Ikarian Capital, LLC | 260,087 | $556,000 | 0.11% |
MYDA Advisors LLC | 100,000 | $214,000 | 0.10% |
Privium Fund Management B.V. | 113,528 | $253,000 | 0.09% |